You are here: Industry Insights > Vaccine

News List

Inovio’s NIH-backed HIV vaccine shows near 100% immune response rate in early test fiercepharma
May 25, 2017
Inovio is one step closer in the race to create an effective HIV vaccine. Data from an early-stage clinical study showed that its Pennvax-GP could elicit an immune response in nearly all participants.
Limited domestic vaccine manufacturing endangers U.S. flu prep, GAO report says fiercepharma
May 18, 2017
The U.S. could run into a vaccine supply predicament if an influenza pandemic hits, since only one drugmaker has a U.S. facility with egg-based vaccine production capabilities.
Merck's Ebola vaccine candidate could see early action against new Congo outbreak fiercepharma
May 18, 2017
Merck & Co. and other biopharma players hustled to develop Ebola vaccines amid a devastating West Africa epidemic that started in 2014. Now, before Merck’s shot wins an official license, it could be used to combat a new outbreak in Congo.
'Groundbreaking Strides' Made in Zika Vaccine Research drugs.com
May 11, 2017
Development of a Zika vaccine is proceeding rapidly, but it still will be years before such a vaccine is available to the public, says the author of a new report on research efforts.
Tangle of global regs adds to risk of vaccine shortages, Sanofi Pasteur executive says fiercepharma
May 10, 2017
Worried about emerging diseases, pharma has increasingly teamed with governments and nonprofits to work on vaccines to combat them.
Pfizer, Merck KGaA join with cancer vaccine biotech Vaximm for Bavencio combo studies fiercepharma
May 10, 2017
Vaximm signed up with Pfizer and Merck KGaA to test its cancer vaccine with Bavencio in glioblastoma and metastatic colorectal cancer.
GSK ends Vaxem Hib production, costing Takeda a planned launch in Japan fiercepharma
May 10, 2017
Takeda’s plan to launch a Haemophilus influenzae type B (Hib) vaccine in Japan has ended in smoke as manufacturer GlaxoSmithKline has terminated production of Vaxem Hib.
Hookipa Biotech Presents Positive Data from Phase 1 First-In-Human Trial of Vaccine Against Cytomega b3cnewswire
May 05, 2017
Vaccine was safe and elicited a potent immune response;Cytomegalovirus (CMV) infection is the leading cause of birth defects in the developed world, occurring in 1 – 2.5 % of all newborns and conferring risk of deafness and impaired intellectual developm
Health ministry to launch pneumonia vaccine on May 13 financialexpress
May 04, 2017
In the first phase, the vaccine will be administered under routine immunisation programme in parts of Bihar, Uttar Pradesh and entire Himachal Pradesh
Secretive Moderna reveals first-in-human data from mRNA vaccine tech fiercepharma
May 03, 2017
Moderna just provided its first human efficacy data from an avian influenza vaccine candidate. (Moderna)

Previous page 1 2 3 4 5 6 7 8 9 10 ... 99 100 Next page